2026 NPPES data General Practice Registered Nurse NPI 1831802867
Verify on CMS →

MAYLISSAH CESAR

General Practice Registered Nurse in BROOKLYN, New York. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
474
Medicare Part D claims · 52 beneficiaries · General Practice Registered Nurse avg: 1K
Generic prescribing
92%
generic claims · 8% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$22.47
1 payments · CMS Open Payments (Sunshine Act)
What the federal data reveals: MAYLISSAH CESAR is a General Practice Registered Nurse ([object Object]) practicing in BROOKLYN, New York with a Medicare Part D prescribing footprint of 474 claims across 52 beneficiaries — 8% brand-name prescribing . Industry payments of $22.47 across 1 transactions are disclosed under CMS Open Payments (Sunshine Act).

What stands out: MAYLISSAH CESAR filed 474 Medicare Part D claims in 2023 across BROOKLYN, New York. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.

MAYLISSAH CESAR at a glance

Quality data not reported

NPI registry status

Active

Issued 01/04/2023

NPI 1831802867

Primary specialty

General Practice Registered Nurse

Mid-sized

5,478 US NPIs in this specialty

Medicare Part D claims

474 60% vs specialty avg

2023 prescription claims

Specialty avg: 1,187

Specialty distribution in New York

How General Practice Registered Nurse compares to other specialties among New York providers

New York providers

General Practice Registered Nurse share within New York

1. General Practice Registered Nurse42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
General Practice Registered Nurse share within New York

Specialty board-certification context

Estimated specialty board-certified rate — General Practice Registered Nurse (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
General Practice Registered Nurse ABMS/AOA estimate

Est. board-certified rate (General Practice Registered Nurse) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (General Practice Registered Nurse) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

MAYLISSAH CESAR is a General Practice Registered Nurse provider practicing in BROOKLYN, New York, according to the CMS National Plan and Provider Enumeration System (NPPES). NPI: 1831802867. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

MAYLISSAH CESAR appears in the CMS NPPES registry as a General Practice Registered Nurse provider at 1 BROOKDALE PLZ, BROOKLYN, NY, 11212, with a listed phone of (718) 240-5000. NPI 1831802867 was issued on 01/04/2023. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what CESAR most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 474 prescription claims written by this provider, covering 52 Medicare beneficiaries and totaling roughly $21K in drug spend, split 8% brand-name and 92% generic by claim count, with an opioid prescribing rate of 12.2%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

General Practice Registered Nurse is a mid-sized specialty nationwide, with 5,478 enrolled providers across 55 states and an average of 1,187 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

1 BROOKDALE PLZ
BROOKLYN, NY 11212

Provider Details

NPI 1831802867
Specialty General Practice Registered Nurse
Gender Female
NPI Issued 01/04/2023

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for MAYLISSAH CESAR. Source: openpaymentsdata.cms.gov.

Total received

$22

Largest payer

PFIZER INC.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — New York NYSBPMC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~100K New York medical licensees in 2023 — they are NOT specific to MAYLISSAH CESAR. To verify MAYLISSAH CESAR's current license status, search the NYSBPMC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

312
Total board actions, New York 2023
Across 302 cases
3.12
Actions per 1,000 licensees
New York statewide rate
probation
Most common action type
89 cases

NYSBPMC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the New York disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Generic-heavy

MAYLISSAH CESAR — brand share 8.0%
Specialty average (est.)

8% brand-name claims vs 92% generic, on 474 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

474
Total Claims
$21K
Total Drug Cost
52
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
474
Total Day Supply
8,711
Brand vs Generic
8% brand / 92% generic
Brand Drug Cost
$11K
Generic Drug Cost
$10K
Opioid Claims
58 (12.2% rate)
Antibiotic Claims
42

Patient Demographics

Average Patient Age
77.6 years
Avg HCC Risk Score
2.84
Gender Split
65% female / 35% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Lorazepam
50
Clonazepam
40
Oxycodone Hcl
23
Alprazolam
19
Gabapentin
19
Lisinopril
17
Metformin Hcl
15
Phenobarbital
15
Tramadol Hcl
15
Levothyroxine Sodium
13

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

General Practice Registered Nurse Overview

How MAYLISSAH CESAR fits within the General Practice Registered Nurse landscape nationally.

5,478
General Practice Registered Nurse Providers in US
55
States with General Practice Registered Nurse
1,187
Avg Claims per Provider

MAYLISSAH CESAR's 474 claims are below the specialty average of 1,187.

Nearby General Practice Registered Nurse Providers in New York

Other clinicians with the same primary specialty enrolled in New York, drawn from the same CMS NPPES roster as CESAR.

Compare General Practice Registered Nurse nationally: see state-by-state distribution →

Frequently Asked Questions

What is MAYLISSAH CESAR's specialty?
MAYLISSAH CESAR specializes in General Practice Registered Nurse and practices in BROOKLYN, New York.
How much does MAYLISSAH CESAR prescribe under Medicare Part D?
In 2023, MAYLISSAH CESAR wrote 474 Medicare Part D claims totaling $21K in drug costs for 52 beneficiaries.
Where is MAYLISSAH CESAR located?
MAYLISSAH CESAR is located at 1 BROOKDALE PLZ, BROOKLYN, NY, 11212. Phone: (718) 240-5000.
What is MAYLISSAH CESAR's NPI number?
MAYLISSAH CESAR's National Provider Identifier (NPI) is 1831802867, issued on 01/04/2023.
Does MAYLISSAH CESAR prescribe more brand-name or generic drugs?
MAYLISSAH CESAR's prescribing is 8% brand-name and 92% generic drugs by claim count, with $11K in brand drug costs.
Does MAYLISSAH CESAR prescribe opioids?
Yes, MAYLISSAH CESAR had 58 opioid claims in 2023 with an opioid prescribing rate of 12.2%.
How many General Practice Registered Nurse providers are there in the US?
There are 5,478 General Practice Registered Nurse providers across 55 states in the US. The average General Practice Registered Nurse provider writes 1,187 Medicare Part D claims per year.
What drugs does MAYLISSAH CESAR prescribe most often?
Based on 2023 Medicare Part D data, MAYLISSAH CESAR's most frequently prescribed drugs include Lorazepam, Clonazepam, Oxycodone Hcl. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does MAYLISSAH CESAR accept Medicare?
MAYLISSAH CESAR appears in CMS Medicare data with 474 Part D claims and 52 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify MAYLISSAH CESAR's credentials?
MAYLISSAH CESAR's NPI is 1831802867. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology